American Association for Cancer Research
00085472can190020-sup-214694_4_supp_5707162_pw5fk7.docx (24.88 MB)

Supplementary Figures from The Cdk2–c-Myc–miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting Geminin

Download (24.88 MB)
journal contribution
posted on 2023-03-31, 02:25 authored by Yi Zhang, Zhuqing Li, Qiang Hao, Wei Tan, Jing Sun, Jing Li, Chi-wei Chen, Zongzhu Li, Yunxiao Meng, Yuan Zhou, Zhiyong Han, Huadong Pei, Melvin L. DePamphilis, Wenge Zhu

Supplementary Figure 1. miR-571 regulates DNA re-replication Supplementary Figure 2. Geminin is the major target by miR-571 to regulate DNA re-replication. Supplementary Figure 3. miR-571 regulates DNA replication and S phase cell cycle progression Supplementary Figure 4. c-Myc negatively regulates miR-571 and its host gene Supplementary Figure 5. c-Myc regulates miR-571 expression Supplementary Figure 6. Cdk2 regulates DNA replication through c-Myc Supplementary Figure 7. Phosphorylation of c-Myc at Ser62 by Cdk2 regulates miR-571 expression Supplementary Figure 8. miR-571 induced DNA re-replication is independent of mitotic failure



American Cancer Society



DNA rereplication leads to genomic instability and has been implicated in the pathology of a variety of human cancers. Eukaryotic DNA replication is tightly controlled to ensure it occurs only once during each cell cycle. Geminin is a critical component of this control, it prevents DNA rereplication from occurring during S, G2, and early M phases by preventing MCM helicases from forming prereplication complexes. Geminin is targeted for degradation by the anaphase-promoting complex (APC/C) from anaphase through G1-phase, however, accumulating evidence indicates that Geminin is downregulated in late S-phase due to an unknown mechanism. Here, we used a high-throughput screen to identify miRNAs that can induce excess DNA replication and found that miR-571 could reduce the protein level of Geminin in late S-phase independent of the APC/C. Furthermore, miR-571 regulated efficient DNA replication and S-phase cell-cycle progression. Strikingly, c-Myc suppressed miR-571 expression by binding directly to the miR-571 promoter. At the beginning of S-phase, Cdk2 phosphorylated c-Myc at Serine 62, promoting its association with the miR-571 promoter region. Collectively, we identify miR-571 as the first miRNA that prevents aberrant DNA replication and the Cdk2–c-Myc–miR-571 axis as a new pathway for regulating DNA replication, cell cycle, and genomic stability in cancer cells. These findings identify a novel regulatory mechanism that is critical for maintaining genome integrity by regulating DNA replication and cell-cycle progression.

Usage metrics

    Cancer Research



    Ref. manager